7-(1-Butyl-4-(3-hydroxyoctyl)-2-oxopyrrolidin-3-yl)heptanoic acid CAS 62311-17-5
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 62311-17-5 |
| Molecular Formula | C23H43NO4 |
| Molecular Weight | 397.59 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Order 7-(1-Butyl-4-(3-hydroxyoctyl)-2-oxopyrrolidin-3-yl)heptanoic acid (CAS 62311-17-5) pharmaceutical standards reference standard from CATO: ISO 17034 accredited producer, 130,000+ catalog items in stock. Molecular formula: C23H43NO4. Molecular weight: 397.59 g/mol. COA included with every batch.
Physical & Chemical Properties
| Molecular Formula | C23H43NO4 |
| Molecular Weight | 397.59 g/mol |
| Appearance | White to pale yellow crystalline powder |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 3.0 |
| UV Absorption | UV-absorbing |
| CAS Registry Year (est.) | 1974 |
| Nitrogen Atoms | 1 |
Related Butyl Standards
- 7-(4-(3-Hydroxyoctyl)-1-methyl-2-oxopyrrolidin-3-yl)heptanoic acid (CAS 62311-16-4)
- 7-(2-(3-Hydroxyoctyl)-5-oxopyrrolidin-1-yl)heptanoic acid (CAS 64054-40-6)
- 2-(8-Hydroxyoctyl)isoindoline-1,3-dione (CAS 105264-63-9)
- 4-((8-Hydroxyoctyl)oxy)benzoic acid (CAS 140918-53-2)
- 3-(1-Hydroxyoctyl)-5-methylfuran-2(5H)-one (CAS 144398-20-9)
- (8-Hydroxyoctyl)triphenylphosphonium bromide (CAS 65734-62-5)
Recommended Standards
- N-(2-(2,4-di-tert-butylphenoxy)ethyl)-4-isobutoxyaniline (CAS 1040688-35-4)
- 4-HPR 65646-68-6 D08JAC Fenretinide Fenretinide (Ewing's sarcoma), Cancer Research UK Fenretinide (ILE formulation), Children's Hospital LA Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx Fenretinide (intravenous, cancer), SciTech Development Fenretinide (iv), Children's Hospital LA Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products Fenretinide (oral, AMD), Sytera Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University Fenretinide (soft gel capsule, AMD), ReVision Therapeutics Fenretinide (soft gel capsule, AMD), Sirion Fenretinide (topical, actinic keratosis and cancer), SciTech Development LXS/4-HPR N-(4-hydroxyphenyl)retinamide RT-101 ST-602 SYT-101 (CAS 65646-68-6)
- N-{2-[4-(tert-Butyl)phenoxy]propyl}-3-(heptyloxy)aniline (CAS 1040680-39-4)
- 4-Cyclopropylthiophene-2-carbaldehyde (CAS 893738-62-0)
- 2-methylimidazo[1,2-a]pyridine-3-carbaldehyde (CAS 30384-93-1)
- (S)-2-((Ethoxycarbonyl)amino)propanoic acid (CAS 16639-86-4)
- 5-Iodo-1H-indazol-3-ol (CAS 141122-62-5)
- (3-Aminophenyl)dimethylphosphine oxide (CAS 26728-38-1)
- (2S,3R,4S,5R,6R)-2-(allyloxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol (CAS 201858-29-9)
- (Des-His1,Glu?)-Glucagon (1-29) amide (human, rat, porcine) (CAS 110084-95-2)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com